Eaton Vance Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $801K | Buy |
8,277
+91
| +1% | +$8.81K | ﹤0.01% | 1268 |
|
|
2022
Q2 | $860K | Sell |
8,186
-12,822
| -61% | -$1.35M | ﹤0.01% | 1284 |
|
|
2022
Q1 | $3.62M | Buy |
21,008
+8,731
| +71% | +$1.5M | ﹤0.01% | 983 |
|
|
2021
Q4 | $1.99M | Buy |
12,277
+3,741
| +44% | +$605K | ﹤0.01% | 1026 |
|
|
2021
Q3 | $1.14M | Sell |
8,536
-414
| -5% | -$55.3K | ﹤0.01% | 1063 |
|
|
2021
Q2 | $2.19M | Buy |
8,950
+1,565
| +21% | +$383K | ﹤0.01% | 992 |
|
|
2021
Q1 | $1.96M | Sell |
7,385
-473
| -6% | -$125K | ﹤0.01% | 980 |
|
|
2020
Q4 | $2.31M | Sell |
7,858
-10,371
| -57% | -$3.04M | ﹤0.01% | 896 |
|
|
2020
Q3 | $4.31M | Sell |
18,229
-75,758
| -81% | -$17.9M | 0.01% | 669 |
|
|
2020
Q2 | $18.7M | Sell |
93,987
-13,107
| -12% | -$2.6M | 0.04% | 344 |
|
|
2020
Q1 | $19.7M | Sell |
107,094
-108,784
| -50% | -$20M | 0.05% | 306 |
|
|
2019
Q4 | $36M | Sell |
215,878
-13,287
| -6% | -$2.22M | 0.07% | 239 |
|
|
2019
Q3 | $30M | Buy |
229,165
+19,865
| +9% | +$2.6M | 0.06% | 247 |
|
|
2019
Q2 | $25.4M | Buy |
209,300
+22,994
| +12% | +$2.79M | 0.06% | 268 |
|
|
2019
Q1 | $23M | Buy |
186,306
+13,994
| +8% | +$1.72M | 0.05% | 272 |
|
|
2018
Q4 | $20.2M | Sell |
172,312
-22,867
| -12% | -$2.68M | 0.05% | 263 |
|
|
2018
Q3 | $24.4M | Sell |
195,179
-101,689
| -34% | -$12.7M | 0.05% | 257 |
|
|
2018
Q2 | $25.4M | Sell |
296,868
-392,238
| -57% | -$33.5M | 0.06% | 252 |
|
|
2018
Q1 | $41.6M | Buy |
689,106
+350,618
| +104% | +$21.2M | 0.05% | 268 |
|
|
2017
Q4 | $17.8M | Buy |
338,488
+136,001
| +67% | +$7.17M | 0.04% | 293 |
|
|
2017
Q3 | $11.3M | Buy |
202,487
+19,780
| +11% | +$1.11M | 0.03% | 354 |
|
|
2017
Q2 | $11.5M | Buy |
182,707
+15,462
| +9% | +$971K | 0.03% | 346 |
|
|
2017
Q1 | $8.55M | Buy |
+167,245
| New | +$8.55M | 0.02% | 380 |
|